US biotechnology company Moderna Inc, one of the two leading makers of mRNA vaccines for COVID-19, on Tuesday announced that it would establish four subsidiaries in Taiwan, Hong Kong, Malaysia and Singapore to support delivery of its vaccines and therapeutics.
The subsidiary in Taiwan is expected to be set up by the end of this year, Moderna told Chinese-language media, adding that it would recruit local talent and collaborate with local hospitals on clinical trials.
Moderna has signed a contract with Taiwan to offer 20 million COVID-19 vaccine and booster doses this year, and another 15 million next year, the company said in a statement.
Photo: Reuters
In Taiwan, its COVID-19 vaccine has been approved for people aged 18 or older, while its booster shots can be given to those who had their second dose five months prior, it said.
Moderna provides Taiwan with its mRNA-1273 vaccine, which targets variants of SARS-CoV-2, and it is developing a next-generation vaccine that it expects to launch in the second half of this year, pending regulatory approval, Moderna senior vice president Patrick Bergstedt said in an interview with the Chinese-language United Daily News.
“This is why we set up a subsidiary in Taiwan — we hope to cooperate with local hospitals and regulators directly so that we could provide our vaccine,” United Daily News quoted Bergstedt as saying.
More studies are required to determine whether booster shots should be given once every six months or once a year, he said.
Moderna did not say whether it would consider manufacturing its COVID-19 vaccine in Taiwan, but the Central News Agency (CNA) yesterday reported that the government is attempting to arrange a technology transfer for the vaccine.
To facilitate a transfer, the government plans to set up a new company in which the National Development Fund would hold a stake of less than 49 percent and the remaining shares would belong to private companies, CNA reported.
South Korea’s Samsung Biologics Co has since May last year been assigned the fill and finish manufacturing task for Moderna’s COVID-19 vaccines, corporate data showed.
Minister of Health and Welfare Chen Shih-chung (陳時中) last year told lawmakers that the US is protective of its mRNA technology, so there would be a higher chance of Taiwan participating in the back-end manufacturing processes, such as fill and finish — the process of filling vials with vaccine and finishing the process of packaging the medicine — than in core manufacturing.
However, Taiwan would strive to transfer the technology, he said.
Asked whether Moderna’s decision to set up a branch in Taiwan could lead to the company’s vaccines being produced in Taiwan or other types of cooperation, Chen yesterday said that the ministry does not know the company’s development plans, but welcomes it to Taiwan and would not exclude the possibility of further cooperation.
Moderna said that the addition of the four subsidiaries comes as it continues to scale up the manufacturing and distribution of its COVID-19 vaccine, and future mRNA vaccines and therapeutics.
The Asia-Pacific region represents an integral part of Moderna’s business, with established subsidiaries in Australia, South Korea and Japan, it said.
Additional reporting by Lee I-chia
MORE VISITORS: The Tourism Administration said that it is seeing positive prospects in its efforts to expand the tourism market in North America and Europe Taiwan has been ranked as the cheapest place in the world to travel to this year, based on a list recommended by NerdWallet. The San Francisco-based personal finance company said that Taiwan topped the list of 16 nations it chose for budget travelers because US tourists do not need visas and travelers can easily have a good meal for less than US$10. A bus ride in Taipei costs just under US$0.50, while subway rides start at US$0.60, the firm said, adding that public transportation in Taiwan is easy to navigate. The firm also called Taiwan a “food lover’s paradise,” citing inexpensive breakfast stalls
TRADE: A mandatory declaration of origin for manufactured goods bound for the US is to take effect on May 7 to block China from exploiting Taiwan’s trade channels All products manufactured in Taiwan and exported to the US must include a signed declaration of origin starting on May 7, the Bureau of Foreign Trade announced yesterday. US President Donald Trump on April 2 imposed a 32 percent tariff on imports from Taiwan, but one week later announced a 90-day pause on its implementation. However, a universal 10 percent tariff was immediately applied to most imports from around the world. On April 12, the Trump administration further exempted computers, smartphones and semiconductors from the new tariffs. In response, President William Lai’s (賴清德) administration has introduced a series of countermeasures to support affected
CROSS-STRAIT: The vast majority of Taiwanese support maintaining the ‘status quo,’ while concern is rising about Beijing’s influence operations More than eight out of 10 Taiwanese reject Beijing’s “one country, two systems” framework for cross-strait relations, according to a survey released by the Mainland Affairs Council (MAC) on Thursday. The MAC’s latest quarterly survey found that 84.4 percent of respondents opposed Beijing’s “one country, two systems” formula for handling cross-strait relations — a figure consistent with past polling. Over the past three years, opposition to the framework has remained high, ranging from a low of 83.6 percent in April 2023 to a peak of 89.6 percent in April last year. In the most recent poll, 82.5 percent also rejected China’s
PLUGGING HOLES: The amendments would bring the legislation in line with systems found in other countries such as Japan and the US, Legislator Chen Kuan-ting said Democratic Progressive Party (DPP) Legislator Chen Kuan-ting (陳冠廷) has proposed amending national security legislation amid a spate of espionage cases. Potential gaps in security vetting procedures for personnel with access to sensitive information prompted him to propose the amendments, which would introduce changes to Article 14 of the Classified National Security Information Protection Act (國家機密保護法), Chen said yesterday. The proposal, which aims to enhance interagency vetting procedures and reduce the risk of classified information leaks, would establish a comprehensive security clearance system in Taiwan, he said. The amendment would require character and loyalty checks for civil servants and intelligence personnel prior to
RSS